Orchestrating Established and Innovative Therapies to Achieve Optimal Care in SCLC Latest Evidence, Key Ongoing Trials, and Practical Considerations for Real-World Practice
- Provider:PVI, PeerView Institute for Medical Education
- Activity Link: https://www.peerview.com/HXN
- Start Date: 2024-06-03 05:00:00
- End Date: 2024-06-03 05:00:00
- Credit Details: IPCE Credits: 1.5 hours
AAPA Category 1 Credit™️: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours - MOC Credit Details: ABIM - 1.5 Point; Credit Type(s): Medical Knowledge (ABIM)
ABIM - 1.5 Point; Credit Type(s): Patient Safety (ABIM) - Commercial Support: Source: Amgen, Inc. - Amount: 25820.0 - Is Kind Support: False Source: AstraZeneca (Any division) - Amount: 9181.0 - Is Kind Support: False Source: Daiichi Sankyo, Inc. - Amount: 22382.0 - Is Kind Support: False Source: Jazz Pharmaceuticals, Inc. - Amount: 40165.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest